Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD.
Claus von der BurchardFelix TreumerChristoph EhlkenStefan KoinzerKonstantine PurtskhvanidzeJan TodeJohann RoiderPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2018)
Fluid detection without further characterization is not sufficient for AMD monitoring. Either further distinction between exudative and degenerative cysts is necessary, or other activity markers have to be taken into account. MRV offers good potential to fill this diagnostic gap and might become an important monitoring marker.
Keyphrases
- age related macular degeneration
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- optical coherence tomography
- rheumatoid arthritis patients
- ankylosing spondylitis
- diabetic retinopathy
- juvenile idiopathic arthritis
- optic nerve
- loop mediated isothermal amplification
- vascular endothelial growth factor
- endothelial cells
- risk assessment